Frontier Path VC
Venture capitalLondon · Growth–Late Stage · 1 people tracked
Investment thesis
Frontier Path targets post-revenue technology companies with validated market and product fit across smart healthcare (medical devices, digital health, wellness), smart mobility (electric vehicles, autonomous transport), and smart environment sectors (cybersecurity, agriculture, fintech, logistics). The firm emphasizes companies with strong technology foundations and business models, seeking both secondary and primary investment opportunities globally with a concentration in North American markets.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 6 of 7 portfolio companiesHealthtech ×5Biotech ×3Medical Devices ×2AI & Machine Learning ×1Cleantech ×1Climate Tech ×1Cybersecurity ×1Deep Tech ×1
HQs:United States×4
Investments · 7 tracked
founders shown can be your intro pathBreaking develops engineered microorganisms and enzymes—notably a microbe variant called MICROBE X-32—that biologically degrade many types of plastic waste into organic matter.
BiotechCleantechClimate Tech
Sukanya Punthambaker(Founder)Vaskar Gnyawali(Founder)George Church(Founder)Donald Ingber(Co-founder)Alba Tull(Founder)Kent Wakeford(Founder)
Co-investorsCarnrite Ventures
Cylera provides a healthcare cybersecurity platform focused on connected medical devices, IoT, and IT assets, giving hospitals and health systems visibility, risk assessment, and threat detection across their environments.
CybersecurityHealthtechIoTNew York, US
Timur Ozekcin(Executive Officer, Director)Sean Abraham(Executive Officer, Director)Apostolos Bakoyiannis(Executive Officer)Owen Wilson(Director)
Co-investorsContour Venture PartnersDreamit VenturesEpsilon Health InvestorsGreat Oaks Venture CapitalRho Capital PartnersRho Ventures+1 more
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)
Co-investorsAera VCFrontera Technology VenturesJames Beshara FundJLSMagnetic VenturesNoetic+4 more
HealthtechSan Francisco, US
Amit Vohra(Executive Officer, Director)Abhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)
BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)
Co-investorsShangBay Capital LLC
Paradromics develops brain-computer interface (BCI) technology, building a neural implant platform intended for clinical use to help people through direct connection to the brain.
Deep TechHealthtechMedical Devices
Co-investors15th RockAlpha EdisonAnthropy PartnersCapital FactoryCoastCapFusion+7 more
Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions.
BiotechHardwareHealthtechMedical DevicesOakland, US
Amit Vohra(Executive Officer, Director)Michael Bartholomew(Executive Officer, Director)Dinesh Kumar(Executive Officer)
BoardJonathan Chen(Director)Derek Hennecke(Director)inDushyant Chipalkatty(Director)
Co-investorsAngel Physicians FundBand of Angels
Portfolio news
latest coverage across their companies
Gilgamesh Pharmaceuticals · wmbdradio.com · Jul 16, 2026
Frequently asked questions
- How many investments has Frontier Path VC made?
- Frontier Path VC has 7 tracked investments.
- What stage does Frontier Path VC invest at?
- Frontier Path VC invests at the Growth, Late Stage stages.
- What sectors does Frontier Path VC focus on?
- Frontier Path VC focuses on AgTech, AI & Machine Learning, Circular Economy, Cybersecurity, Data & Infrastructure, Deep Tech, Digital Health, E-commerce, EdTech, Fintech, FoodTech, Healthtech, Logistics & Supply Chain, Medical Devices, Mobility & Transportation, PropTech, Wellness & Fitness.
- Where is Frontier Path VC located?
- Frontier Path VC is headquartered in London, GB.
- Who does Frontier Path VC co-invest with?
- Frontier Path VC most often shares deals with Prime Movers Lab, Capital Factory, Great Oaks Venture Capital, among 32 tracked co-investors.
Co-investors · 1
Flyer One Ventures is an early-stage venture capital fund led and backed by entrepreneurs who built one of the largest tech companies in Central and Eastern Europe. It partners with CEE and Ukrainian founders building the application layer of global software.
Firms observed investing alongside Frontier Path VC, from public investor directories. Shared companies are the overlap with Frontier Path VC's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
LVX Ventures (LetsVenture) operates an AI-native private-market investing platform connecting investors and family offices with early-stage startups, and manages an angel fund.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.